EP Patent

EP2895457B1 — Oligomer-containing benzamide-based compounds

Assigned to Nektar Therapeutics · Expires 2020-05-20 · 6y expired

What this patent protects

Patent listed against naloxegol-oxalate.

Drugs covered by this patent

Patent Metadata

Patent number
EP2895457B1
Jurisdiction
EP
Classification
—
Expires
2020-05-20
Drug substance claim
No
Drug product claim
No
Assignee
Nektar Therapeutics
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.